Holen Sie sich die Stockscreener-App
18.61
0.76%
0.14
Schlusskurs vom Vortag:
$18.47
Offen:
$18.6
24-Stunden-Volumen:
956.33K
Relative Volume:
0.55
Marktkapitalisierung:
$1.35B
Einnahmen:
-
Nettoeinkommen (Verlust:
$84.01M
KGV:
21.74
EPS:
0.856
Netto-Cashflow:
$-101.16M
1W Leistung:
-7.32%
1M Leistung:
-1.33%
6M Leistung:
+70.73%
1J Leistung:
+341.00%
1-Tages-Spanne:
$18.21
$18.76
1-Wochen-Bereich:
$18.21
$20.38
52-Wochen-Spanne:
$4.055
$21.24
Omeros Corp Stock (OMER) Company Profile
Firmenname
Omeros Corp
Sektor
Branche
Telefon
206-676-5000
Adresse
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Compare OMER vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMER
Omeros Corp
|
18.61 | 1.45B | 0 | 84.01M | -101.16M | 0.856 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Omeros Corp Stock (OMER) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-23 | Eingeleitet | D. Boral Capital | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-12-08 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-06-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-10-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2021-10-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2021-09-27 | Eingeleitet | JP Morgan | Neutral |
| 2021-02-01 | Eingeleitet | UBS | Buy |
| 2020-10-20 | Eingeleitet | BofA Securities | Buy |
| 2020-08-21 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-14 | Bestätigt | Maxim Group | Buy |
| 2019-05-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-07-12 | Eingeleitet | Seaport Global Securities | Buy |
| 2018-03-23 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-03-05 | Herabstufung | Needham | Buy → Hold |
| 2017-11-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Herabstufung | Cantor Fitzgerald | Buy → Neutral |
| 2017-03-17 | Bestätigt | Maxim Group | Buy |
| 2017-03-17 | Bestätigt | Needham | Buy |
| 2016-11-16 | Bestätigt | Wedbush | Outperform |
| 2016-11-10 | Bestätigt | Needham | Buy |
| 2016-08-10 | Bestätigt | Maxim Group | Buy |
| 2016-06-03 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-02 | Bestätigt | Needham | Buy |
| 2016-02-29 | Bestätigt | Wedbush | Outperform |
| 2015-11-11 | Bestätigt | Needham | Buy |
| 2015-08-18 | Bestätigt | WBB Securities | Strong Buy |
| 2015-08-10 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Omeros Corp Aktie (OMER) Neueste Nachrichten
ETFs Investing in Omeros Corporation Stocks - TradingView
Press Releases about Omeros CorporationCommon Stock (Nasdaq:OMER) - FinancialContent
Form 4 Omeros Corporation For: 24 September By Investing.com - Investing.com India
Omeros VP finance David Borges sells $419,000 in shares By Investing.com - Investing.com South Africa
Omeros VP finance David Borges sells $419,000 in shares - Investing.com
Omeros (OMER) finance VP exercised options and sold shares at $20.95 apiece under a trading plan. - Stock Titan
AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst – A Look At Some Key Highlights - Stocktwits
Stock options are the source of shares in officer David Borges's proposed Omeros (OMER) sale. - Stock Titan
Omeros Corporation (OMER) Stock Price, News, Quote & History - Yahoo Finance
Omeros (NASDAQ: OMER) officer to sell 10,000 shares via option exercise - Stock Titan
Omeros Corp (OMER) Hits 52-Week High as Cantor Fitzgerald Upgrades on Yartemlea Sales Outlook - GuruFocus
NTRA Stock Hits All-Time High, OMER Stock Scales 5-Year Peak – What’s Driving Investors’ Enthusiasm Today? - Stocktwits
Omeros Shares Rise After Cantor Fitzgerald Upgrade - marketscreener.com
Omeros Transplant Drug Could Be Bigger than Expected, Says Analyst - Benzinga
Omeros Corporation stock hits 52-week high at 19.75 USD By Investing.com - Investing.com Australia
Omeros Corporation stock hits 52-week high at 19.75 USD - Investing.com
OMER Upgraded by Cantor Fitzgerald -- Rating Raised to Overweigh - GuruFocus
This Plexus Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Cantor Fitzgerald upgrades Omeros stock rating on Yartemlea launch - Investing.com
Cantor Fitzgerald upgrades Omeros stock rating on Yartemlea launch By Investing.com - Investing.com Nigeria
OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism - Stocktwits
Omeros Stock Price Forecast. Should You Buy OMER? - StockInvest.us
Omeros Corporation (OMER) Slides 4.49% to $18.52, Drifting Toward Key SupportKAMA Signal - careplusvn.com
Omeros Corp VP and General Counsel Peter B. Cancelmo Executes Stock Option Exercises and Sells Shares - Kalkine Media
Omeros Insider Sold Shares Worth $929,668, According to a Recent SEC Filing - marketscreener.com
Omeros VP, finance & CAO David Borges sells $206,804 in shares By Investing.com - Investing.com South Africa
Omeros VP, finance & CAO David Borges sells $206,804 in shares - Investing.com Nigeria
Omeros (NASDAQ: OMER) insider plans second 25,000-share stock sale - Stock Titan
Omeros Insider Sold Shares Worth $282,094, According to a Recent SEC Filing - Yahoo Finance
Omeros (NASDAQ: OMER) director plans 10,000-share sale after 5,000 sold - Stock Titan
Omeros VP of finance David Borges sells $206,804 in shares By Investing.com - Investing.com Nigeria
Omeros VP of finance David Borges sells $206,804 in shares - Investing.com
Omeros Corp (OMER) Director Thomas Cable Sells 15,000 Shares - GuruFocus
Omeros director Thomas Cable sells $276,772 in company stock - Investing.com
Omeros director Thomas Cable sells $276,772 in company stock By Investing.com - Investing.com Canada
Omeros (NASDAQ:OMER) Director Thomas Cable Sells 15,000 Shares - MarketBeat
Omeros (NASDAQ: OMER) officer to sell 10,906 shares - Stock Titan
Omeros Insider Sold Shares Worth $276,773, According to a Recent SEC Filing - Yahoo Finance
Omeros Corp (OMER) director lines up fresh stock sale - Stock Titan
Pomerantz investigates Omeros after CHMP negative opinion - scanx.trade
Omeros (NASDAQ:OMER) Sets New 52-Week HighStill a Buy? - MarketBeat
Omeros stock hits 52-week high at 18.16 USD - Investing.com
Omeros stock hits 52-week high at 18.16 USD By Investing.com - Investing.com Canada
Omeros Corp (OMER) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Omeros Corp (HAM:3O8) Stock Price, Trades & News - GuruFocus
Omeros VP, finance & CAO Borges sells $84,750 in shares By Investing.com - Investing.com India
Omeros VP, finance & CAO Borges sells $84,750 in shares - Investing.com
Omeros (NASDAQ:OMER) CAO David Borges Sells 5,000 Shares of Stock - MarketBeat
Finanzdaten der Omeros Corp-Aktie (OMER)
Umsatz
Nettogewinn
Free Cashflow
ENV
Omeros Corp-Aktie (OMER) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Borges David J. | VP, Finance & CAO |
Sep 22 '26 |
Option Exercise |
3.44 |
10,000 |
34,350 |
10,000 |
| Borges David J. | VP, Finance & CAO |
Sep 23 '26 |
Sale |
20.95 |
10,000 |
209,500 |
0 |
| Borges David J. | VP, Finance & CAO |
Sep 22 '26 |
Sale |
20.95 |
10,000 |
209,500 |
0 |
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):